A. Gallioli
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by A. Gallioli.
Journal of Pediatric Urology | 2017
Alfredo Berrettini; L. Boeri; E. Montanari; Mirella Mogiatti; P. Acquati; Elisa De Lorenzis; A. Gallioli; Erika Adalgisa De Marco; Dario Guido Minoli; Gianantonio Manzoni
INTRODUCTIONnSurgical treatment of pediatric kidney stones has changed dramatically in recent years because of the miniaturization of surgical instruments and the availability of intracorporeal lithotripters. The retrograde intrarenal surgery (RIRS) technique is nowadays considered an effective and safe procedure but studies in very young children are lacking and use of a ureteral access sheath (UAS) has also been debated.nnnOBJECTIVEnTo assess safety and efficacy of RIRS using UAS in children weighing <xa020xa0kg.nnnMATERIALS AND METHODSnData from 13 children weighing <20xa0kg who underwent RIRS for renal stones were collected. A Double-J stent was positioned 14 days before surgery. Demographics, stone location, stone number and composition, stone-free status (SFS) and complications were evaluated. Descriptive statistics were applied to describe the cohort.nnnRESULTSnThirteen patients, age 3.91xa0±xa01.8 years (meanxa0±xa0SD), underwent 16 RIRS. Mean patient weight and stone burden were 14.88xa0±xa03.81xa0kg (range 10-20xa0kg) and 15.5xa0±xa03.8xa0mm (median 16xa0mm), respectively. A UAS was used in 15 out of 16 (93.8%) procedures. SFS was achieved in 81.3% of cases after the first procedure and 100% after auxiliary procedures. Postoperative urinary tract infections with fever (Clavien II) were observed in two (12.5%) patients. Hydrocalyx (Clavien IIIb) was noted in one (6.3%) patient. Patients with stones located in the lower polar calices (pxa0=xa00.024) and with mixed composition (pxa0=xa00.036) had a greater prevalence of complications than those with calculi of other compositions located in other sites. After a mean follow-up of 22.4 months no cases of ureteral strictures or vesicoureteral reflux were observed (Table).nnnDISCUSSIONnThe current findings support previous evidence showing safety and efficacy of RIRS with use of the UAS in pre-stented very young children. In our experience RIRS seems to be an effective and safe option with a stone-free rate of 81.3% and only 1 severe complication (Clavien-Dindo grade IIIb) and no long-term complications. This study is, to date, the first to examine the safety and efficacy of RIRS using UAS for the treatment of intrarenal stones in a selected cohort of pre-school patients weighing <20xa0kg.nnnCONCLUSIONSnRIRS using UAS is an effective and safe procedure for treating kidney stones in pre-school patients weighing <20xa0kg without complications at both short and long term follow up. Stones of mixed composition located in the lower polar calices are associated with a greater risk of postoperative complications.
BMC Urology | 2017
A. Gallioli; Elisa De Lorenzis; L. Boeri; Maurizio Delor; S.P. Zanetti; Fabrizio Longo; A. Trinchieri; E. Montanari
BackgroundComputed Tomography (CT) is considered the gold-standard for the pre-operative evaluation of urolithiasis. However, no Hounsfield (HU) variable capable of differentiating stone types has been clearly identified. The aim of this study is to assess the predictive value of HU parameters on CT for determining stone composition and outcomes in percutaneous nephrolithotomy (PCNL).MethodsSeventy seven consecutive cases of PCNL between 2011 and 2016 were divided into 4 groups: 40 (52%) calcium, 26 (34%) uric acid, 5 (6%) struvite and 6 (8%) cystine stones. All images were reviewed by a single urologist using abdomen/bone windows to evaluate: stone volume, core (HUC), periphery HU and their absolute difference. HU density (HUD) was defined as the ratio between mean HU and the stone’s largest diameter. ROC curves assessed the predictive power of HU for determining stone composition/stone-free rate (SFR).ResultsNo differences were found based on the viewing window (abdomen vs bone). Struvite stones had values halfway between hyperdense (calcium) and low-density (cystine/uric acid) calculi for all parameters except HUD, which was the lowest. All HU variables for medium-high density stones were greater than low-density stones (pu2009<u20090.001). HUC differentiated the two groups (cut-off 825 HU; specificity 90.6%, sensitivity 88.9%). HUD distinguished calcium from struvite (meanu2009±u2009SD 51u2009±u200916 and 28u2009±u200912 respectively; pu2009=u20090.02) with high sensitivity (82.5%) and specificity (80%) at a cut-off of 35 HU/mm. Multivariate analysis revealed HUDu2009≥u200938.5 HU/mm to be an independent predictor of SFR (ORu2009=u20093.1, pu2009=u20090.03). No relationship was found between HU values and complication rate.ConclusionsHU parameters help predict stone composition to select patients for oral chemolysis. HUD is an independent predictor of residual fragments after PCNL and may be fundamental to categorize it, driving the imaging choice at follow-up.
European Urology Supplements | 2017
L. Boeri; M. Fontana; A. Gallioli; S.P. Zanetti; M. Catellani; E. De Lorenzis; F. Palmisano; F. Longo; E. Montanari
European Urology Supplements | 2018
E. De Lorenzis; L. Boeri; A. Gallioli; S.P. Zanetti; M. Fontana; F. Palmisano; Stefano Luzzago; G. Sampogna; F. Longo; M. Arghittu; R. Colombo; S. Piconi; Andrea Salonia; E. Montanari
European Urology Supplements | 2018
A. Gallioli; L. Boeri; E. De Lorenzis; S.P. Zanetti; G. Sampogna; M. Fontana; F. Palmisano; Stefano Luzzago; F. Longo; G. Malagò; Roberto Brambilla; Mauro Campoleoni; Andrea Salonia; E. Montanari
European Urology Supplements | 2018
M. Fontana; A. Gallioli; E. De Lorenzis; L. Boeri; S.P. Zanetti; F. Palmisano; G. Sampogna; F. Longo; E. Montanari
European Urology Supplements | 2018
S.P. Zanetti; G. Sampogna; M. Fontana; E. De Lorenzis; A. Gallioli; L. Boeri; F. Palmisano; I. Sabatini; Stefano Luzzago; Giancarlo Albo; F. Longo; E. Montanari
European Urology Supplements | 2018
L. Boeri; E. De Lorenzis; A. Gallioli; M. Fontana; S.P. Zanetti; F. Palmisano; G. Sampogna; F. Longo; R. Colombo; M. Arghittu; S. Piconi; Andrea Salonia; Giancarlo Albo; E. Montanari
European Urology Supplements | 2018
S.P. Zanetti; E. De Lorenzis; M. Fontana; A. Gallioli; F. Palmisano; G. Sampogna; L. Boeri; F. Longo; E. Montanari
European Urology Supplements | 2018
Franco Gadda; L. Boeri; F. Palmisano; E. De Lorenzis; A. Gallioli; M. Fontana; S.P. Zanetti; G. Sampogna; Liliana Restelli; Edgardo Somigliana; M. Serrago; Matteo Giulio Spinelli; Andrea Salonia; E. Montanari
Collaboration
Dive into the A. Gallioli's collaboration.
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
View shared research outputsFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
View shared research outputs